Related Experiment Video
Updated: May 21, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Effect of nebulized dexmedetomidine on gag reflex suppression and sedation quality in pediatric patients undergoing
Esra Turunc1, Yasemin Burcu Ustun2, Sezgin Bilgin2
1Department of Anesthesiology and Reanimation, Faculty of Medicine, Ondokuz Mayis University, Kurupelit, Samsun, TR55139, Turkey. esra.kiymaz.ek@gmail.com.
Insights
Nebulized dexmedetomidine significantly reduces gag and cough reflexes in pediatric endoscopy patients. This safe and effective premedication improves patient comfort and procedural success.
Area of Science:
- Pediatric Gastroenterology
- Anesthesiology
- Pharmacology
Background:
- Pediatric upper gastrointestinal (GI) endoscopy often necessitates sedation and analgesia.
- The gag reflex presents a significant challenge during endoscopic probe placement in children.
- Effective management of gag reflex is crucial for successful pediatric GI procedures.
Purpose of the Study:
- To investigate the efficacy of nebulized dexmedetomidine as a premedication in pediatric patients undergoing upper GI endoscopy.
- To assess the impact of nebulized dexmedetomidine on gag reflex severity during pediatric endoscopy.
- To evaluate secondary outcomes including cough, anxiety, agitation, and endoscopist satisfaction.
Main Methods:
- A single-center, prospective, randomized controlled trial was conducted involving pediatric patients aged 2-17 years.
- Participants were randomized to receive either nebulized dexmedetomidine (2 µg/kg) or no premedication.
- Gag reflex severity was the primary outcome; cough, anxiety, agitation, and satisfaction were secondary outcomes.
Main Results:
- Nebulized dexmedetomidine significantly reduced gag reflex incidence (88.3% vs. 30%, p<0.001) and coughing (95% vs. 55%, p<0.001).
- The dexmedetomidine group showed significantly lower separation anxiety scores (p<0.005).
- Reduced need for additional anesthetics and higher endoscopist satisfaction were observed, with no significant increase in complications.
Conclusions:
- Nebulized dexmedetomidine is a safe and effective premedication for pediatric endoscopy.
- It significantly mitigates gag and cough reflexes, enhancing patient comfort and procedural safety.
- This approach improves endoscopist satisfaction and reduces anesthetic requirements in pediatric GI procedures.
Background:
Pediatric patients undergoing upper gastrointestinal (GI) interventions frequently require sedation and analgesia due to the challenges associated with endoscopic probe placement, particularly the gag reflex. This study investigates the effects of nebulized dexmedetomidine as a premedication on the gag reflex in pediatric patients undergoing gastrointestinal endoscopy.
Methods:
We conducted a single-center, prospective, randomized controlled trial at the Pediatric Gastroenterology Clinic of Ondokuz Mayis University School of Medicine from January to April 2024. Participants aged 2-17 years scheduled for upper GI endoscopy were randomized to receive nebulized dexmedetomidine (2 µg /kg) or no premedication. The primary outcome measured was the severity of the gag reflex during the procedure. Secondary outcomes included cough incidence, separation anxiety, postoperative agitation, and endoscopist satisfaction. Statistical analyses were performed with significance set at p < 0.050.
Results:
A total of 120 patients were analyzed. The dexmedetomidine group demonstrated a significantly lower incidence of gag reflex (88.3% with no gag reflex vs. 30% in the control group, p < 0.001) and coughing (95% vs. 55%, p < 0.001). Separation anxiety scores were also significantly lower in the dexmedetomidine group (p < 0.005). Additionally, the need for additional anesthetics was reduced, and endoscopist satisfaction was significantly higher. No significant differences in complications were observed between the two groups (p = 0.600).
Conclusions:
Nebulized dexmedetomidine is a safe and effective premedication for pediatric patients undergoing endoscopic procedures, significantly reducing gag and cough reflexes, decreasing anesthetic requirements, and enhancing endoscopist satisfaction. This approach improves the comfort and safety of pediatric endoscopy procedures.
Trials Registration:
ClinicalTrials.gov: NCT06218797, date of registration 27/12/2023.
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Stages of General Anesthesia
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Depolarizing Blockers: Pharmocokinetics

